Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

54.78 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 448,383
Open 54.78
Bid (Size) 54.09 (2)
Ask (Size) 54.10 (1)
Prev. Close 54.78
Today's Range 54.78 - 54.78
52wk Range 45.05 - 139.74
Shares Outstanding N/A
Dividend Yield 4.01%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year
Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark. 
Via Stocktwits
1 Reason to Buy NVO
There's more to the company's leading product than meets the eye. 
Via The Motley Fool

Performance

YTD
-37.4%
-37.4%
1 Month
-15.6%
-15.6%
3 Month
-19.7%
-19.7%
6 Month
-33.5%
-33.5%
1 Year
-59.5%
-59.5%

More News

Read More
Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug?
Via Benzinga
Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns
Via MarketMinute
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
Via Stocktwits
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
Via Benzinga
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?
Via Benzinga
Why Novo Nordisk Stock Popped Today
Via The Motley Fool
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill
Via Investor's Business Daily
3 Undervalued Healthcare Stocks You Can Buy Now and Hold Long-Term
Via The Motley Fool
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access
Via Benzinga
Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4
Via MarketBeat
Topics Artificial Intelligence
Autonomous Vehicles Hit an Inflection Point; GPT-5 Is Here
Via The Motley Fool
Topics Economy
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday?
Via Benzinga
Topics Government
Dayforce, Applied Digital, GoodRx, First Solar, TeraWulf: Stocks Making The Biggest Moves Today
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows
Via Benzinga
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets
Via Benzinga
Market Movers: UnitedHealth, Intel, and Novo Nordisk Among Top Performers Reshaping the Financial Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Government
Why Novo Nordisk Stock Popped Monday
Via The Motley Fool
Novo Nordisk Stock Surges After Pharma Major Cuts Ozempic Cost to $499 Per Month For Self-Paying Patients
Via Stocktwits
Novo Nordisk Pops On A New Wegovy Approval, Dragging Hard On Madrigal Pharma
Via Investor's Business Daily
Shareholders That Lost Money on Novo Nordisk A/S (NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Via NewMediaWire
Topics Fraud Lawsuit

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 54.78
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 08/19/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.